Sunday, September 20, 2020

Sildenafil and Milrinone Improved Prognosis in Newborns with Persistent Pulmonary Hypertension

A new study has found that a combination of sildenafil (Revatio) and milrinone (Primacor) has proven effective in newborns with severe persistent pulmonary hypertension (PPHN). The study found that the combination of sildenafil and milrinone improved pulmonary artery systolic pressure and oxygen level.

AstraZeneca COVID-19 Vaccine Trial Participant Not Officially Diagnosed With Rare Neurological Condition

AstraZeneca has said in a statement that a sick participant, which halted their Phase III trials of their coronavirus vaccine candidate, has not officially been diagnosed with transverse myelitis, a rare neurological condition characterized by the inflammation of the spinal cord.

FDA Approves Kesimpta for the Treatment of Relapsing Forms of Multiple Sclerosis

The Food and Drug Administration (FDA) has approved the use of ofatumumab (Kesimpta), developed by Novartis, in adult patients with relapsing forms of multiple sclerosis (MS). The drug was initially approved in 2009 for the treatment of chronic lymphocytic leukemia.

Adding Sildenafil to Pirfenidone Found Ineffective In Patients with Advanced Idiopathic Pulmonary Fibrosis

A new trial has found that adding sildenafil to pirfenidone did not provide a clinical benefit in patients with advanced idiopathic pulmonary fibrosis (IPF) and the risk of pulmonary arterial hypertension. The study researchers interpreted that adding sildenafil to pirfenidone was not effective for IPF patients.

Molecular Markers Could Help Treat Gonorrhea Susceptible To Ciprofloxacin, Study

A team of researchers has discovered a new strategy to treat antibiotic-resistant gonorrhea infections. The strategy included genetic testing of a molecular marker in patients susceptible to ciprofloxacin-susceptible gonorrhea. The researchers found the new strategy 100% effective.

Study Finds New Treatment Strategy That Could Treat Multiple Sclerosis

A new study in mice has found that altering a protein called Reelin, produced in the liver, could pave way for a new treatment strategy for patients with multiple sclerosis, a serious neurodegenerative disorder. UTSW researchers found that reducing Reelin helped with MS symptoms in mice.

Blue Pills, Sex, Intimacy, and Bodyform Discussion on the Campaign Podcast

This week’s Campaign podcast is all about bodyform, sex, intimacy, blue pills, erectile dysfunction, and other taboo subjects. The topics of discussion include Bodyform’s #Wombstories and Viagra Connect’s Love Store, which have earned a Campaign Pick of the Week.